Press releases

29 01, 2025

Diatech Pharmacogenetics Expands Collaboration with Merck to Enhance Patient Access to Personalized Medicine in the Middle East and Africa

Diatech Pharmacogenetics2025-01-29T12:10:34+01:00

20 06, 2023

Diatech Pharmacogenetics announces new collaboration to advance precision testing in oncology

Diatech Pharmacogenetics2023-06-19T18:17:17+02:00

8 06, 2023

Oncology, the ‘microenvironment’ is the super challenge of diagnostics Genomic tests are now used to create 50% of drugs. Aiming for 100%, Diatech creates the first expert board for new guidelines

Diatech Pharmacogenetics2023-06-08T10:00:16+02:00

26 04, 2023

Diatech Pharmacogenetics announces Investment from TA to Fuel Strategic Growth Initiatives

Diatech Pharmacogenetics2023-04-25T20:36:11+02:00

28 10, 2015

Diatech Pharmacogenetics e Agena Bioscience: accordo internazionale per la distribuzione di un nuovo sistema diagnostico

Diatech Pharmacogenetics2022-04-08T11:25:43+02:00

28 10, 2015

Agena Bioscience and Diatech Pharmacogenetics Announce Plan to Launch Actionable, Targeted CE-IVD Marked Oncology Assays for Colon, Lung, and Melanoma Treatment

Diatech Pharmacogenetics2017-08-23T09:26:54+02:00

12 06, 2014

Physiomics enters the personalized medicine market. Anticipated new collaboration with Diatech Pharmacogenetics

Diatech Pharmacogenetics2022-04-20T12:45:17+02:00

6 05, 2013

Horizon Discovery and Diatech Pharmacogenetics Sign Distribution Agreement

Diatech Pharmacogenetics2017-09-04T16:46:46+02:00

8 02, 2012

Presentation of the 3rd annual course of Pharmacogenetics and Personalized Medicine

Diatech Pharmacogenetics2020-10-20T16:03:15+02:00

13 12, 2011

Italian Society for Personalized Medicine (SIMeP)

Diatech Pharmacogenetics2017-09-05T17:01:48+02:00